SINGAPORE AND BOSTON , MA – September 3, 2020 – Biofourmis , a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a US$100 million Series C financing round led by SoftBank Vision Fund 2,1 with participation by existing investors Openspace Ventures, MassMutual Ventures, Sequoia
